6,173 Shares in DaVita Inc. (NYSE:DVA) Purchased by Sage Investment Counsel LLC

Sage Investment Counsel LLC acquired a new position in DaVita Inc. (NYSE:DVA) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,173 shares of the company’s stock, valued at approximately $923,000. DaVita accounts for approximately 1.2% of Sage Investment Counsel LLC’s investment portfolio, making the stock its 18th biggest holding.

Other institutional investors have also bought and sold shares of the company. Transcendent Capital Group LLC acquired a new stake in DaVita in the third quarter worth about $25,000. Blue Trust Inc. lifted its holdings in DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after purchasing an additional 119 shares during the period. Quarry LP acquired a new stake in DaVita in the third quarter worth about $60,000. Venturi Wealth Management LLC lifted its holdings in DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after purchasing an additional 152 shares during the period. Finally, Versant Capital Management Inc lifted its holdings in DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Price Performance

NYSE DVA opened at $147.83 on Friday. The stock’s 50-day moving average price is $160.66 and its two-hundred day moving average price is $158.08. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The company has a market cap of $11.83 billion, a PE ratio of 13.76, a PEG ratio of 1.07 and a beta of 0.93. DaVita Inc. has a 1 year low of $124.70 and a 1 year high of $179.60.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Ratings Changes

DVA has been the subject of a number of research analyst reports. Barclays upped their price target on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a report on Friday, February 21st. Finally, Cowen reissued a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.